UNSPSC 51201539: Efalizumab

This classification denotes an immunomodulator, an immunosuppressant, and monoclonal antibody, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XX2MN88N5D. Most nations schedule Efalizumab under HS 30021091 and SITC 54163. SMILES:. As of Q4 2014, EFALIZUMAB remains the US FDA Preferred Term for this commodity.. Efalizumab bears US NLM identifiers UMLS ID C1320125 and NCI Concept Code C68831.

UNSPSC 51201539 Efalizumab, a Commodity code, shows no recent state and local procurement activity aligned with its pharmaceutical scope. The three recent opportunities tagged under this code—a District Attorney's Office Dog from Washington County, Oregon; Athletic Training Services from the City of Tucson; and Medical Aid Supplies from the City of Tampa Fire Rescue—are unrelated to efalizumab or pharmaceutical procurement more broadly. The mismatch suggests these opportunities were miscoded in the source system or that the code itself is not actively used for state and local contracting.

No further analysis of issuing-body patterns, geographic concentration, or representative procurement trends is supported by the available data, as the tagged opportunities do not reflect actual buying activity under this Commodity code.